comprehensive
Previous article:
As demand for Covid shots wanes, Moderna seeks its next success
Next article: Surge in Apellis stock fueled by confidence in safety of its eye drug
Next article: Surge in Apellis stock fueled by confidence in safety of its eye drug
focus
knowledge
-
Listen: A conversation with researcher Kevin Esvelt on biosecurity
2025-09-28 19:29 -
Treatments for cramps don't cut it. Why aren't there better options?
2025-09-28 19:04 -
Scrutiny of post
2025-09-28 18:53 -
Citing H5N1 threat, CDC urges peak flu monitoring this summer
2025-09-28 18:16 -
Scrutiny of post
2025-09-28 18:00 -
Maui wildfire now ranks as the fifth
2025-09-28 17:59